Clinical trials · New York
Cataract clinical trials in New York
We’re tracking 4 recruiting cataract studies with a site in New York — including Early Phase 1 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT05191706RecruitingPhase 4
Check how safe DEXYCU is after childhood cataract surgery
This trial studies whether DEXYCU is safe to use to reduce eye inflammation after cataract surgery in children. It aims to see if the medicine’s side effects are acceptable and whether it helps during normal recovery.
Buffalo, New YorkAges Up to 3 years - NCT06539637RecruitingEarly Phase 1
Ketorolac levels in eye fluid during cataract and vitrectomy surgery
This study looks at how much of the drug ketorolac (a pain and inflammation medicine) gets into the fluid inside your eye when it's given as eye drops during combined cataract and vitrectomy surgery. It may help doctors understand if using another drug called phenylephrine alongside it changes those levels.
Westbury, New YorkAges 18 years+ - NCT04205916RecruitingPhase 4
Preference trial of eye drops versus no-drops after cataract surgery
This trial compares two ways to prevent inflammation and comfort you after cataract surgery: usual antibiotic/steroid eye drops versus a “no-drops” option that is placed during surgery. It mainly looks at patient preference, comfort, and ease of treatment after surgery.
Garden City, New YorkAges 22–100 - NCT07425496Recruiting
Eye fluid dynamics study during surgery
This trial measures eye fluid flow during cataract or glaucoma surgery. It aims to help doctors predict and improve surgery results.
New York, New YorkAges 18 years+
Cataract trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting cataract studies listed above.
- Ophthalmic Consultants of Long Island · 2 studies
- EyePoint Investigational Site
- EyePoint Investigative Site
- Mount Sinai Health System
What taking part in a cataract study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Cataract trials in other states
Common questions
- Are there cataract clinical trials in New York?
- Yes. We're currently tracking 4 recruiting cataract studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a cataract study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a cataract trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New cataract studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.